Treatment Guidelines - 2013
Year:    Publication:
February 1, 2013 (Issue 126)  
March 1, 2013 (Issue 127)  
  • Antiviral Drugs
    The drugs of choice for treatment of viral infections (other than HIV) and their dosages are listed in Tables 1-6 on the pages that follow. Some of the indications and dosages recommended here have not been approved by the FDA. Vaccines used for the prevention of viral infections are discussed...
April 1, 2013 (Issue 128)  
  • Drugs for Pain
    Pain can be acute or chronic. The two major types of chronic pain are nociceptive pain and neuropathic pain. Nociceptive pain can be treated with nonopioid analgesics or opioids. Neuropathic pain is less responsive to opioids and is often treated with adjuvant drugs such as antidepressants and antiepileptics. Combining different types of analgesics may provide an...
May 1, 2013 (Issue 129)  
July 1, 2013 (Issue 131)  
  • Drugs for Bacterial Infections
    The text that follows reviews some common bacterial infections and their empiric treatment pending the results of culture and susceptibility testing. The recommendations made here are based on the results of susceptibility studies, clinical trials, and the opinions of Medical Letter reviewers. Tables 1 and 2 list the usual dosages of antibacterial...
August 1, 2013 (Issue 132)  
  • Drugs for Asthma and COPD
    INHALATION DEVICES — Metered-dose inhalers (MDIs) require coordination of inhalation with hand-actuation of the device. Valved holding chambers (VHCs) or spacers help some patients, especially young children and the elderly, use MDIs effectively. VHCs have one-way valves that prevent the patient from exhaling into the device, minimizing the need for coordinated...
September 1, 2013 (Issue 133)  
October 1, 2013 (Issue 134)  
  • Drugs for Cognitive Loss and Dementia
    Alzheimer's disease (AD) is the most common cause of dementia, but cognitive loss is also associated with other neurological conditions such as Parkinson's disease, dementia with Lewy bodies, and vascular dementia. Mild cognitive impairment (MCI) is generally defined as cognitive decline greater than expected for an individual's age and educational level, but...
November 1, 2013 (Issue 135)  
  • Drugs for Parkinson's Disease
    The motor symptoms of Parkinson's disease (PD) are caused primarily by progressive degeneration of dopaminergic neurons in the substantia nigra. The non-motor symptoms of the disease are thought to be caused by degeneration of other neurotransmitter...
December 1, 2013 (Issue 136)